Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8567)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2018 (publication date) through Apr 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lin CJ, Hu ZG, Yuan GD, Lei B, He SQ. Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis. World J Hepatol 2018; 10(10): 662-669 [PMID: 30386459 DOI: 10.4254/wjh.v10.i10.662] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i10/662.htm |
| Number | Citing Articles |
| 1 |
Thomas Lung, Benjamin Sakem, Lorenz Risch, Reinhard Würzner, Giuseppe Colucci, Andreas Cerny, Urs Nydegger. The complement system in liver diseases: Evidence-based approach and therapeutic options. Journal of Translational Autoimmunity 2019; 2: 100017 doi: 10.1016/j.jtauto.2019.100017
|
| 2 |
Jie Chen, Shujun Zhang. The Role of Inflammation in Cholestatic Liver Injury. Journal of Inflammation Research 2023; : 4527 doi: 10.2147/JIR.S430730
|
| 3 |
Debanjali Dasgupta, Suchandrima Ghosh, Indrashish Dey, Swagata Majumdar, Saheli Chowdhury, Subhas Das, Sanjana Banerjee, Mehelana Saha, Amit Ghosh, Neelanjana Roy, Alak Manna, Sukanta Ray, Shaleen Agarwal, Pradeep Bhaumik, Simanti Datta, Abhijit Chowdhury, Soma Banerjee. Influence of polymorphisms in TNF-α and IL1β on susceptibility to alcohol induced liver diseases and therapeutic potential of miR-124-3p impeding TNF-α/IL1β mediated multi-cellular signaling in liver microenvironment. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1241755
|
| 4 |
Zhenya Guo, Junze Chen, Yonglian Zeng, Zefeng Wang, Mei Yao, Stephen Tomlinson, Bin Chen, Guandou Yuan, Songqing He. Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice. Frontiers in Immunology 2022; 12 doi: 10.3389/fimmu.2021.785287
|
| 5 |
Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang. Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization. Clinical and Molecular Hepatology 2024; 30(2): 150 doi: 10.3350/cmh.2024.0116
|
| 6 |
Sumit Kr Anand, Ankita Sharma, Neha Singh, Poonam Kakkar. Activation of autophagic flux via LKB1/AMPK/mTOR axis against xenoestrogen Bisphenol-A exposure in primary rat hepatocytes. Food and Chemical Toxicology 2020; 141: 111314 doi: 10.1016/j.fct.2020.111314
|
| 7 |
Lazara Elena Santiesteban-Lores, Milena Carvalho Carneiro, Lourdes Isaac, Lorena Bavia. Complement System in Alcohol-Associated Liver Disease. Immunology Letters 2021; 236: 37 doi: 10.1016/j.imlet.2021.05.007
|
| 8 |
Kirill S. Nikolsky, Arthur T. Kopylov, Valeriya I. Nakhod, Natalia V. Potoldykova, Dmitry V. Enikeev, Tatiana V. Butkova, Liudmila I. Kulikova, Kristina A. Malsagova, Vladimir R. Rudnev, Denis V. Petrovskiy, Alexander A. Izotov, Anna L. Kaysheva. Plasma proteome fingerprint in kidney diseases. Frontiers in Molecular Biosciences 2025; 11 doi: 10.3389/fmolb.2024.1494779
|
| 9 |
Yu Li, Xiaodan Ping, Yankang Zhang, Guoqiang Li, Ting Zhang, Geng Chen, Xinran Ma, Dongmei Wang, Lingyan Xu. Comparative Transcriptome Profiling of Cold Exposure and β3-AR Agonist CL316,243-Induced Browning of White Fat. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.667698
|
| 10 |
Bang‐Yan Li, Qian‐Qian Mao, Ren‐You Gan, Shi‐Yu Cao, Xiao‐Yu Xu, Min Luo, Hang‐Yu Li, Hua‐Bin Li. Protective effects of tea extracts against alcoholic fatty liver disease in mice via modulating cytochrome P450 2E1 expression and ameliorating oxidative damage. Food Science & Nutrition 2021; 9(10): 5626 doi: 10.1002/fsn3.2526
|
| 11 |
Xiude Fan, Rebecca L. McCullough, Emily Huang, Annette Bellar, Adam Kim, Kyle L. Poulsen, Craig J. McClain, Mack Mitchell, Arthur J. McCullough, Svetlana Radaeva, Bruce Barton, Gyongyi Szabo, Srinivasan Dasarathy, Daniel M. Rotroff, Laura E. Nagy. Diagnostic and Prognostic Significance of Complement in Patients With Alcohol‐Associated Hepatitis. Hepatology 2021; 73(3): 983 doi: 10.1002/hep.31419
|
| 12 |
Olfa Khalifa, Khalid Ouararhni, Khaoula Errafii, Nehad M. Alajez, Abdelilah Arredouani. Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells. International Journal of Molecular Sciences 2023; 24(14): 11606 doi: 10.3390/ijms241411606
|
| 13 |
Huali Xiang, Binfeng Tu, Ming Luo, Ping Hou, Jiakun Wang, Rongguiyi Zhang, Linquan Wu. Knockdown of UCA1 attenuated the progression of alcoholic fatty disease by sponging miR-214. Mammalian Genome 2022; 33(3): 534 doi: 10.1007/s00335-022-09953-0
|
| 14 |
Kayla L Frost, Joseph L Jilek, Austin D Thompson, Robert R Klein, Shripad Sinari, Elmira Torabzedehkorasani, Dean D Billheimer, Rick G Schnellmann, Nathan J Cherrington. Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination. Toxicological Sciences 2022; 189(1): 62 doi: 10.1093/toxsci/kfac070
|
| 15 |
Beth G. Gibson, Thomas E. Cox, Kevin J. Marchbank. Contribution of animal models to the mechanistic understanding of Alternative Pathway and Amplification Loop (AP/AL)‐driven Complement‐mediated Diseases. Immunological Reviews 2023; 313(1): 194 doi: 10.1111/imr.13141
|